Vaccine Development Related News
A Milestone in Global Health: A New Polio Vaccine Approved For Emergency Use
In a major breakthrough for global health, a new polio vaccine has received WHO prequalification. This innovative vaccine addresses persistent challenges and strengthens efforts...
Revolutionising the fight against Ebola
In a new special report, B Medical Systems, a medical cold chain innovator, delves into the fight against the Ebola virus, its impact over...
NIH-sponsored trial of nasal COVID-19 vaccine opens
A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2,...
Measles vaccine less likely to work for C-section children
Researchers from the University of Cambridge have emphasised that children born by caesarean section must receive two doses of the measles vaccine for robust...
Defence Therapeutics strengthens and expands global patent protection on key technologies
Defence Therapeutics Inc. has announced the issuance of several new patents and new allowances of patent applications belonging to different Patent Families in Defence’s...
Duke University creates long-lasting flu vaccine
Duke University researchers have unveiled a promising breakthrough in the ongoing battle against influenza viruses.
Their pioneering research has developed a universal, long-lasting flu vaccine...
Trial demonstrates ARM-002TM vaccine’s effectiveness against pancreatic cancer
Defence Therapeutics has announced a successful pre-clinical vaccination trial utilising its ARM-002TM vaccine against pancreatic cancer.
ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma
Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine.
The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...
Discover B Medical Systems’ medical refrigerators, freezers, and transport boxes
B Medical Systems S.a r.l (formely Dometic/Electrolux) is a global manufacturer and distributor of innovative vaccine storage solutions, including vaccine cold chain and medical...
mRNA vaccines: are they the way forward?
mRNA vaccine technology is broadening the scope of effective vaccine-based solutions that can mitigate the spread of harmful pathogens in infectious and non-infectious diseases.
For...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
Defence Therapeutics begin toxicology study on intranasal AccutoxTM
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the start...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
New discovery could lead Epstein-Barr virus vaccines
Researchers from MedUni Vienna have found a specific immune response to the virus Epstein-Barr virus that could help the development of new vaccines.
The research...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
Defence Therapeutics are using Accum technology in mRNA vaccines
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is currently working on combining its...
Is it time TB vaccines were improved?
A new study commissioned by the World Health Organization (WHO) has predicted high health and economic returns from investment in new TB vaccines.
According to...
Towards the next Council conclusions: are we doing enough for adult immunisation?
Ahead of a meeting between EU health ministers on vaccination policy in November this year, Mariano Votta and Daniela Quaggia from the Active Citizenship...
WHO: First data released on the global vaccine market since COVID
The World Health Organization (WHO) has captured the effects of COVID-19 on global vaccine markets in a new report.
WHO’s Global Vaccine Market Report...
The teenage meningitis vaccine delivers herd immunity to all ages
Researchers from the University of Oxford have found that the UK’s MenACWY meningitis vaccine programme generates herd protection protecting all age groups.
In the new...